Why is Biden wanting to Distribute 500 Million Home Test Kits Amid COVID-19 Omicron Wave and pays $5 Billion for New Pill?
Editors Note: There are only 330 Million People in the United States, of which 60% are vaccinated and 120,000 million at least have already had one of the China Virus variations and have natural immunity. Why would you buy 500 million test kits and mail them to every US Household so people can obsess about testing to see if they have Covid? Could this be the back door way to create the national vaccine databases the Biden Communist want so badly? Will you have to register to get the test results? What we need is testing for IMMUNITY not testing for Covid! How susceptable are you to getting sick is the question people need answered! How much immunity do you have? Where is the test kit for that??? Then Biden orders $5 Billion of new Pfizer pill, Paxlovid, which is taken twice per day for five days in combination with a second medicine called ritonavir, classified as a generic antiviral drug to keep people from having to go to the hospital. So, how is this new pill different than Hydroxycloriquine and Ivermectin??? Why are they prohibiting these inexpensive drugs that have been proven to work worldwide in favor of this new RUSHED expensive pill? Is it all about the money and not science or medicine? You decide.
By Jack Philips, TheEpochtimes.com, December 22, 2021
President Joe Biden’s administration is planning to mail out some 500 million COVID-19 tests, starting in January, according to the White House.
The White House on Tuesday said it will send the test kits to homes as part of an effort to deal with the Omicron COVID-19 variant, which the Centers for Disease Control and Prevention (CDC) on Monday said accounts for about 73 percent of cases in the United States. It’s not clear yet whether the variant causes more severe disease than previous variants, although fewer than a dozen deaths have been reported worldwide.
“Today, the President is announcing his Administration will purchase a half-billion at-home, rapid tests this winter to be distributed for free to Americans who want them, with the initial delivery starting in January 2022,” the White House said in a press statement.
Additional federal test sites will also be set up across the United States in the coming days, starting in New York City, according to the White House, in a bid to help “states that need additional testing capacity.”
Tuesday’s announcement appears to reverse a previous White House position on COVID-19 testing. White House press secretary Jen Psaki earlier this month told reporters that the administration won’t be mailing test kits to every home.
In the press release, the White House confirmed it will send 1,000 members of the military such as military doctors, nurses, paramedics, and other medical personnel to hospitals in January and February.
Six emergency response teams with more than 100 staff members are also being sent to Michigan, Indiana, Wisconsin, Arizona, New Hampshire, and Vermont, said the White House. Meanwhile, Federal Emergency Management Agency (FEMA) response teams will be sent to add capacity to hospitals in some states, and the federal government is “paying for all of it,” the statement added.
Click Here to Watch the Newest We the People Convention News and Opinion Podcast!
“This is on top of the 300 federal medical personnel that we have deployed since we learned about Omicron,” the news release said.
The CDC Monday reported that Omicron is rapidly spreading and may be the dominant variant in the country, representing some 73 percent of sequenced U.S. cases. The Delta strain, which emerged earlier this year, makes up about 26.6 percent of infections, while just a week before that, Delta represented 87 percent of cases.
FDA Authorizes Pfizer’s COVID-19 Pill Weeks After Landing $5 Billion Deal With Biden Administration
by Jack Philips, TheEpochTimes.com, December 22, 2021
The Food and Drug Administration (FDA) on Dec. 22 granted emergency use authorization to Pfizer’s COVID-19 treatment pill—coming about a month after the federal government announced it would purchase 10 million courses of the drug.
The pill, Paxlovid, is taken twice per day for five days in combination with a second medicine called ritonavir, classified as a generic antiviral drug. The drug is aimed to help patients who are suffering from “mild-to-moderate” COVID-19 symptoms from becoming so sick that they need to be hospitalized, officials and Pfizer have said.
“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally—a major step forward in the fight against this global pandemic,” Dr. Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said in a statement about the agency’s approval.
The drug, available only via prescription, can be initiated as soon as possible following a positive diagnosis of COVID-19, the disease caused by the CCP (Chinese Communist Party) virus.
“This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19,” Cavazzoni said.
But the pill isn’t designed to be used for “pre-exposure or post-exposure prevention” of the CCP virus or for individuals who have been hospitalized due to severe or critical COVID-19, the FDA said in the statement.
The agency also stressed that the drug can’t be a substitute for vaccination and again recommended the common COVID-19 vaccines or booster shots.
The Biden administration has already purchased some 10 million courses of Paxlovid in a more than $5 billion agreement. In November, the White House announced that the federal government would work to ensure treatments are free and accessible for the general public.
Delivery will begin by the start of 2022 and will continue through the remainder of the year, according to the Department of Health and Human Services. Meanwhile, Pfizer CEO Albert Bourla told news outlets earlier this month that his firm already shipped the drug to the United States, saying it would be ready when the FDA granted an emergency use authorization.
“This breakthrough therapy, which has been shown to significantly reduce hospitalizations and deaths and can be taken at home, will change the way we treat COVID-19,” Bourla said Dec. 22 in a statement.
The FDA decision comes about a week after Pfizer reported that its new oral drug is able to reduce the risk of death or hospitalization from the CCP virus by up to 89 percent if it is taken shortly after symptoms appear.
Before the FDA decision, the only COVID-19 antiviral treatment that had been granted emergency authorization by the FDA is remdesivir, a drug that’s being sold under the brand name Veklury.
In recent months, some severely sick COVID-19 patients and their family members have said that the cheaply produced anti-parasitic drug ivermectin produced positive results. An elderly patient in Illinois recovered following a court order that allowed him to use the medication, which the FDA hasn’t cleared for use for COVID-19, the man’s attorney said on Dec. 1.
The FDA, meanwhile, is weighing a COVID-19 pill from Merck and Ridgeback Biotherapeutics that—like Pfizer’s pill—is meant to be taken twice per day for five days.
CLICK HERE TO READ MORE ON THIS TOPIC AT THEEPOCHTIMES.COM